The Motley Fool fool.com 02 Aug, 2022 19:00 am

Idexx Laboratories (IDXX) Q2 2022 Earnings Call Transcript

IDXX earnings call for the period ending June 30, 2022.

As we look forward to the second half of 2022, we're targeting continued solid organic revenue growth, building on the significant expansion of IDEXX's business through the pandemic.The midpoint of this updated range reflects an outlook for continued solid organic gains in the second half, aided by strong IDEXX execution trends and benefits from incremental price increases.Given these factors in a challenging global economic climate, our midpoint organic growth outlook incorporates expectations for continued pressure on clinical visit levels in the second half of 2022.5% organic growth risk estimate in the second half related to higher potential macroeconomic impacts on demand.

5% to 3% increases in the second half of 2021.clinic visit growth in the second half of this year.

Read full story at fool.com